Josef Weismuller
Overview
Explore the profile of Josef Weismuller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schroder J, Chegwidden L, Maj C, Gehlen J, Speller J, Bohmer A, et al.
Gut
. 2022 Jul;
72(4):612-623.
PMID: 35882562
Objective: Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal adenocarcinoma (EA), with Barrett's oesophagus (BE) as a precursor lesion, is the most prevalent EC subtype in...
2.
Wang X, Gharahkhani P, Levine D, Fitzgerald R, Gockel I, Corley D, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Jun;
31(9):1735-1745.
PMID: 35709760
Background: Over 20 susceptibility single-nucleotide polymorphisms (SNP) have been identified for esophageal adenocarcinoma (EAC) and its precursor, Barrett esophagus (BE), explaining a small portion of heritability. Methods: Using genetic data...
3.
Dighe S, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, et al.
Carcinogenesis
. 2020 Dec;
42(3):369-377.
PMID: 33300568
Genome-wide association studies (GWAS) of esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE), have uncovered significant genetic components of risk, but most heritability remains unexplained. Targeted assessment of genetic...
4.
Weismuller J, Thieme R, Hoffmeister A, Weismuller T, Gockel I
Laryngorhinootologie
. 2020 Apr;
99(4):214-223.
PMID: 32314335
Though showing an increasing incidence over the past 20 years, esophageal adenocarcinoma (EAC) remains a rather uncommon cancer (i. e., compared to colorectal and gastric cancer). Once detected, the prognosis...
5.
Schroder J, Schuller V, May A, Gerges C, Anders M, Becker J, et al.
PLoS One
. 2020 Jan;
14(12):e0227072.
PMID: 31891614
Esophageal adenocarcinoma (EA) and its precancerous condition Barrett's esophagus (BE) are multifactorial diseases with rising prevalence rates in Western populations. A recent meta-analysis of genome-wide association studies (GWAS) data identified...
6.
Bohmer A, Hecker J, Schroder J, Gharahkhani P, May A, Gerges C, et al.
Cancer Epidemiol Biomarkers Prev
. 2019 Nov;
29(2):427-433.
PMID: 31748258
Background: Obesity is a major risk factor for esophageal adenocarcinoma (EA) and its precursor Barrett's esophagus (BE). Research suggests that individuals with high genetic risk to obesity have a higher...
7.
Weismuller J, Thieme R, Hoffmeister A, Weismuller T, Gockel I
Z Gastroenterol
. 2019 Mar;
57(3):317-326.
PMID: 30861556
Though showing an increasing incidence over the past 20 years, esophageal adenocarcinoma (EAC) remains a rather uncommon cancer (i. e., compared to colorectal and gastric cancer). Once detected, the prognosis...
8.
Dong J, Gharahkhani P, Chow W, Gammon M, Liu G, Caldas C, et al.
Clin Gastroenterol Hepatol
. 2019 Feb;
17(11):2227-2235.e1.
PMID: 30716477
Background & Aims: Epidemiology studies of circulating concentrations of 25 hydroxy vitamin D (25(OH)D) and risk of esophageal adenocarcinoma (EAC) have produced conflicting results. We conducted a Mendelian randomization study...
9.
Gharahkhani P, Fitzgerald R, Vaughan T, Palles C, Gockel I, Tomlinson I, et al.
Lancet Oncol
. 2016 Aug;
17(10):1363-1373.
PMID: 27527254
Background: Oesophageal adenocarcinoma represents one of the fastest rising cancers in high-income countries. Barrett's oesophagus is the premalignant precursor of oesophageal adenocarcinoma. However, only a few patients with Barrett's oesophagus...
10.
Becker J, May A, Gerges C, Anders M, Schmidt C, Veits L, et al.
Cancer Med
. 2016 Jan;
5(5):888-91.
PMID: 26783083
Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) represent two stages within the esophagitis-metaplasia-dysplasia-adenocarcinoma sequence. Previously genetic risk factors have been identified that confer risk to BE and EAC development. However,...